DanielDMikolMDPhD

PubMed

• 2 citations
  Long‐term efficacy and safety of erenumab in migraine prevention: results from a 5‐year, open‐label treatment phase of a randomized clinical trial
  Messoud Ashina, Peter J. Goadsby, Uwe Reuter, Stephen D. Silberstein, David W. Dodick, Fei Xue, Feng Zhang, Gabriel Paiva da Silva Lima, Sunfa Cheng, Daniel D. Mikol> ;European Journal of Neurology. 2021 Jan 20
• A phase 2, randomized, double-blind, placebo-controlled trial of AMG 301, a pituitary adenylate cyclase-activating polypeptide PAC1 receptor monoclonal antibody for mi...
  Messoud Ashina, David Doležil, Jo H. Bonner, Lifen Zhou, Jan Klatt, Hernan Picard, Daniel D. Mikol> ;Cephalalgia. 2021 Jan 1
• Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a post-hoc analysis of a randomized, 12-week, double-blind study and...
  Richard B. Lipton, Stewart J. Tepper, Stephen D. Silberstein, David Kudrow, Messoud Ashina, Uwe Reuter, David W. Dodick, Feng Zhang, Gregory A Rippon, Sunfa Cheng, Dan...> ;Cephalalgia. 2021 Jan 1
• The Spectrum of Response to Erenumab in Patients With Episodic Migraine and Subgroup Analysis of Patients Achieving ≥50%, ≥75%, and 100% Response.
  Gregor Broessner, Uwe Reuter, Jo H. Bonner, David W. Dodick, Yngve Hallstrom, Hernan Picard, Feng Zhang, Robert A. Lenz, Jan Klatt, Daniel D. Mikol> ;Headache. 2020 Oct 1
• 1 citations
  Efficacy and safety of erenumab in women with a history of menstrual migraine
  Jelena M. Pavlovic, Koen Paemeleire, Hartmut Göbel, Jo H. Bonner, Alan M. Rapoport, Risa Kagan, Feng Zhang, Hernan Picard, Daniel D. Mikol> ;Journal of Headache and Pain. 2020 Aug 3
• 1 citations
  One-year sustained efficacy of erenumab in episodic migraine: Results of the STRIVE study.
  Peter J. Goadsby, Uwe Reuter, Yngve Hallström, Gregor Broessner, Jo H. Bonner, Feng Zhang, Ian K. Wright, Denise E. Chou, Jan Klatt, Hernan Picard, Robert A. Lenz, Dan...> ;Neurology. 2020 Aug 4
• 12 citations
  Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension study.
  Stewart J. Tepper, Messoud Ashina, Uwe Reuter, Jan Lewis Brandes, David Doležil, Stephen D. Silberstein, Paul Winner, Feng Zhang, Sunfa Cheng, Daniel D. Mikol> ;Cephalalgia. 2020 Mar 26
• 10 citations
  Vascular safety of erenumab for migraine prevention.
  David Kudrow, Julio Pascual, Paul Winner, David W. Dodick, Stewart J. Tepper, Uwe Reuter, Frank Hong, Jan Klatt, Feng Zhang, Sunfa Cheng, Hernan Picard, Osa Eisele, Ju...> ;Neurology. 2020 Feb 4
• 5 citations
  The spectrum of response to erenumab in patients with chronic migraine and subgroup analysis of patients achieving ≥50%, ≥75%, and 100% response.
  Jan Lewis Brandes, Hans-Christoph Diener, David Dolezil, Marshall C. Freeman, Peter McAllister, Paul Winner, Jan Klatt, Sunfa Cheng, Feng Zhang, Shihua Wen, Shannon Ri...> ;Cephalalgia. 2020 Jan 1
• 11 citations
  Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine: A pooled analysis of...
  Messoud Ashina, David Kudrow, Uwe Reuter, David Dolezil, Stephen D. Silberstein, Stewart J. Tepper, Fei Xue, Hernan Picard, Feng Zhang, Andrea Wang, Yanchen Zhou, Fran...> ;Cephalalgia. 2019 Nov 10
• 8 citations
  A Randomized Phase 2 Study of Erenumab for the Prevention of Episodic Migraine in Japanese Adults.
  Fumihiko Sakai, Takao Takeshima, Yoshihisa Tatsuoka, Koichi Hirata, Robert A. Lenz, Yi Wang, Sunfa Cheng, Toshiyasu Hirama, Daniel D. Mikol> ;Headache. 2019 Nov 1
• 4 citations
  Evaluating the Psychometric Properties of the Migraine Functional Impact Questionnaire (MFIQ)
  Ariane K. Kawata, Asha Hareendran, Shannon Shaffer, Sally Mannix, Andrew V. Thach, Pooja Desai, Daniel D. Mikol, Brian G. Ortmeier, Martha S. Bayliss, Dawn C. Buse> ;Headache. 2019 Sep 1
• 1 citations
  Letter to the editor: European headache federation guidelines on the use of monoclonal antibodies acting on the calcitonin gene-related peptide or its receptor for mig...
  Daniel D. Mikol, Josefin Snellman> ;Journal of Headache and Pain. 2019 Jun 4
• 22 citations
  Long-term safety and tolerability of erenumab: Three-plus year results from a five-year open-label extension study in episodic migraine:
  Messoud Ashina, Peter J. Goadsby, Uwe Reuter, Stephen D. Silberstein, David W. Dodick, Gregory A Rippon, Jan Klatt, Fei Xue, Victoria M. Chia, Feng Zhang, Sunfa Cheng,...> ;Cephalalgia. 2019 May 30
• Correction to: A Multi‑Center, Open‑Label, Pharmacokinetic Drug Interaction Study of Erenumab and a Combined Oral Contraceptive in Healthy Females.
  Yang Xu, Kristin Gabriel, Yi Wang, Yanchen Zhou, Osaro Eisele, Apinya Vutikullird, Daniel D Mikol, Edward Lee> ;CNS drugs. 2019 May 1
• 19 citations
  Erenumab in chronic migraine: Patient-reported outcomes in a randomized double-blind study.
  Richard B. Lipton, Stewart J. Tepper, Uwe Reuter, Stephen D. Silberstein, Walter F. Stewart, Jon Nilsen, Dean Leonardi, Pooja Desai, Sunfa Cheng, Daniel D. Mikol, Robe...> ;Neurology. 2019 May 7
• 40 citations
  Erenumab in chronic migraine with medication overuse: Subgroup analysis of a randomized trial.
  Stewart J. Tepper, Hans-Christoph Diener, Messoud Ashina, Jan Lewis Brandes, Deborah I. Friedman, Uwe Reuter, Sunfa Cheng, Jon Nilsen, Dean Leonardi, Robert A. Lenz, D...> ;Neurology. 2019 May 14
• Efficacy and safety of erenumab (AMG334) in episodic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, plac...
  Peter J Goadsby, Koen Paemeleire, Gregor Broessner, Jan Brandes, Jan Klatt, Feng Zhang, Hernan Picard, Robert Lenz, Daniel D Mikol> ;Cephalalgia : an international journal of headache. 2019 Jun 1
• A Multi-Center, Open-Label, Pharmacokinetic Drug Interaction Study of Erenumab and a Combined Oral Contraceptive in Healthy Females.
  Yang Xu, Kristin Gabriel, Yi Wang, Yanchen Zhou, Osaro Eisele, Apinya Vutikullird, Daniel D Mikol, Edward Lee> ;CNS drugs. 2019 May 1
• 4 citations
  Development of a New Tool for Evaluating the Benefit of Preventive Treatments for Migraine on Functional Outcomes - The Migraine Functional Impact Questionnaire (MFIQ)
  Asha Hareendran, Anne Skalicky, Sally Mannix, Sara Lavoie, Pooja Desai, Martha S. Bayliss, Andrew V. Thach, Daniel D. Mikol, Dawn C. Buse> ;Headache. 2018 Nov 1
• 16 citations
  Early onset of efficacy with erenumab in patients with episodic and chronic migraine
  Todd J. Schwedt, Uwe Reuter, Stewart J. Tepper, Messoud Ashina, David Kudrow, Gregor Broessner, Guy P Boudreau, Peter McAllister, Thuy Vu, Feng Zhang, Sunfa Cheng, Her...> ;Journal of Headache and Pain. 2018 Oct 1
• 3 citations
  Use of existing electronic health care databases to evaluate medication safety in pregnancy: Triptan exposure in pregnancy as a case study.
  Akeem Yusuf, Victoria M. Chia, Fei Xue, Daniel D. Mikol, Lisa Bollinger, Charles B. Cangialose> ;Pharmacoepidemiology and Drug Safety. 2018 Dec 1
• Efficacy and safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, place...
  Messoud Ashina, Stewart Tepper, Jan Lewis Brandes, Uwe Reuter, Guy Boudreau, David Dolezil, Sunfa Cheng, Feng Zhang, Robert Lenz, Jan Klatt, Daniel D Mikol> ;Cephalalgia : an international journal of headache. 2018 Sep 1
• 17 citations
  Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab.
  Dawn C. Buse, Richard B. Lipton, Yngve Hallström, Uwe Reuter, Stewart J. Tepper, Feng Zhang, Sandhya Sapra, Hernan Picard, Daniel D. Mikol, Robert A. Lenz> ;Cephalalgia. 2018 Aug 7
• 24 citations
  A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Erenumab on Exercise Time During a Treadmill Test in Patients With Stable Angina.
  Christophe Depre, Lubomir Antalik, Amaal J. Starling, Michael Koren, Osaro Eisele, Robert A. Lenz, Daniel D. Mikol> ;Headache. 2018 May 1
• Join now to see all